Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study

James Chih Hsin Yang, Wu Chou Su, Chao Hua Chiu, Her Shyong Shiah, Kang Yun Lee, Te Chun Hsia, Makiko Uno, Nigel Crawford, Hiroshi Terakawa, Wen Chi Chen, Gensuke Takayama, Ching Hsu, Ying Hong, Carline Saintilien, Joseph McGill, Gee Chen Chang

研究成果: 雜誌貢獻 › 文章 › 同行評審

2 引文 斯高帕斯（Scopus）

指紋

深入研究「Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science